Introduction
Insulin initiates its effects by binding to cell-surface receptors, called insulin receptors. The insulin receptor is an insulin-activated tyrosine-specific protein kinase. The dominant form of the receptor has the structure a2Pz, with the subunits linked by disulphide bonds to give a P-a-a-P structure. The a-subunits ( M , 135 000) appear to be located wholly extracellularly and function to bind insulin.
In contrast, the P-subunits ( M , 95000) act as a transmembrane anchor and contain tyrosine kinase active sites within their cytosolic domains [ 11. The tyrosine kinase catalyses very rapid autophosphorylation of its own P-subunit on multiple tyrosines. Insulin-stimulated autophosphorylation functions to activate the insulin receptor tyrosine kinase to phosphorylate other proteins and renders the tyrosine kinase constitutively active even when insulin is subsequently removed from the binding site [2] . Abolition of tyrosine kinase activity by mutation of Lys-1018 involved in ATP binding does not alter insulin binding, but abrogates cellular responses to insulin [ 3, 41. Therefore the tyrosine kinase activity of the insulin receptor appears essential for signal transduction.
In intact cells insulin also induces phosphorylation of serine and threonine residues of the Psubunit (see, for example, [S] ). This is believed to occur via the activation of protein serinelthreonine kinases that are distinct from the receptor itself [6, 71. W e have been particularly interested in characterizing the insulin-stimulated insulin receptor serine kinase (IRSK). As this kinase can closely
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associate with the insulin receptor it has the potential to be an early cascade enzyme in insulin signalling [7] . Additionally, as phorbol ester-and cyclic AMP-stimulated insulin receptor serine phosphorylation apparently inhibit insulin receptor tyrosine kinase activity [8, 01 , the IKSK has the potential also to control insulin receptor function, perhaps by limiting the lifetime of the activated receptor [ 101.
Studies into the identity, nature and mechanism of activation by insulin of IRSK, together with investigations into the location of sites of insulin-stimulated serine/threonine phosphorylation in the insulin receptor, are described in the first part of this article. The second part of this article is concerned with the characterization of protein-tyrosine phosphatases (PTPases) active against the insulin receptor, and in particular the use of P'I'Pases to probe the role of the various tyrosine autophosphorylation sites in the regulation of insulin receptor tyrosine kinase activity.
Insulin-stimulated insulin receptor serine kinase
At the time of the initiation of the IKSK project there was a dearth of in vitro systems that showed a high activity of the IRSK. Thus, although the insulin receptor underwent significant insulin-stimulated tyrosine and serine phosphorylation in intact cells, at that time most preparations of partially purified or purified insulin receptor described in the literature exhibited only insulin-stimulated tyrosine phosphorylation. This inhibited study of the IRSK. Thus the initial objective was to obtain a system in which a high activity of the IRSK could be demonstrated reproducibly. This was achieved by partially Volume 20 purifying the insulin receptor from human placenta under refined conditions 161. In particular, care was taken to preserve a potentially fragile association between the insulin receptor and IRSK, by using gentle homogenization conditions to prepare membranes. Additionally it was found that NaCI, which has often been included during wheat-germ-agglutinin-agarose chromatography to improve insulin receptor yield, decreased the yield of IRSK (by -80% at 0.5 \I NaCI). With the insulin receptor/ IRSK preparation, insulin increased serine ( > 10-fold) as well as tyrosine ( -fourfold) phosphorylation. Approximately 22 k 4% (mean k s t.: M ) of "P recovered in phosphoamino acids was present as phosphoserine. Phosphorylations at 0"C, as commonly performed in the past, decreased phosphoserine:phosphotyrosine ratios twofold compared with those obtained at 22°C.
Insulin receptor tyrosine kinase activity/ autophosphorylation appears to be essential for activation of the IRSK by insulin
If insulin receptor tyrosine kinase activity or autophosphorylation is essential for activation of the IKSK by insulin, insulin receptor autophosphorylation on tyrosine would be expected to precede serine phosphorylation. This was found to be the case. In the presence of insulin, phosphorylation of the insulin receptor/IRSK preparation revealed that autophosphorylation on tyrosine was rapid and 50% complete in approximately 1 min. Phosphorylation on serine occurred after a pronounced lag and took 5-10 min to reach 50% completion [ l l ] . Therefore, initial stimulation by insulin of insulin receptor tyrosine kinase activity precedes serine phosphorylation. This is similar to the situation in intact cells [XI. T o test more rigorously whether triggering of serine phosphorylation of the insulin receptor by insulin required the tyrosine kinase activity of the insulin receptor, the tyrosine kinase activity was manipulated with a wide range of inhibitors and activators [ 111. Inhibition of insulin receptor tyrosine kinase activity, as measured by autophosphorylation, with a range of methods including use of peptide 1142-1 153 of the insulin receptor which acted as a competing substrate and antiphosphotyrosine antibodies which locked the tyrosine kinase in a low-activity form, all inhibited the activity of insulin to stimulate phosphorylation of the insulin receptor on serine. Additionally, direct stimulation of the receptor tyrosine kinase activity by vanadate increased phosphorylation of the insulin receptor on serine. These data provide strong evidence that insulin-stimulated serine phosphorylation of the insulin receptor requires an active tyrosine kinasel autophosphorylation. This conclusion is supported by the observation that mutation of Lys-1018 which renders the tyrosine kinase completely inactive also abolishes insulin-stimulated serine phosphorylation of the insulin receptor in intact cells [4] . Autoradiographs prepared by Tavark and Dickens [ 121 show that substitution of the autophosphorylation site Tyr-1 1 50 for phenylalanine results in large decreases in the levels of both tyrosine and serine phosphorylation in the presence of insulin, in vitro and in vivo. Thus, these results also parallel our findings.
Given the correlation between tyrosine kinase activity/insulin receptor autophosphorylation and serine phosphorylation, there appear to be three major models for the mechanism of activation of the IRSK by insulin, which could operate individually or in various combinations. First, autophosphorylation of the insulin receptor on tyrosine makes the receptor a better substrate for the IRSK. This model alone seems unlikely because insulin stimulates the insulin receptor/IRSK preparation to phosphorylate histone [ 111 and synthetic peptides (see below [7, 131) on serine, implying that insulin increases the catalytic activity of the serine kinase per se.
Second, activation of the IRSK is achieved by phosphorylation on tyrosine catalysed by the insulin receptor. Third, the IRSK is activated by binding to autophosphorylated insulin receptor. This model is analogous to that proposed for the activation of phosphatidylinositol 3-kinase by binding via a src homology-2 domain to phosphorylated tyrosines in growth factor receptors [ 141. An observation has been made which might argue against the second model; i.e., an insulin receptor mutated at Tyr-1150, which cannot attain the fully activated tyrosine kinase form required for optimum substrate phosphorylation (see below), apparently mediates some insulin stimulation of serine phosphorylation of the insulin receptor (albeit at a reduced level) [12] . Future studies are required to test whether the IRSK can be activated by phosphorylation on tyrosine.
IRSK appears t o be a novel kinase
The question of whether the IliSK is related to any of the known serine kinases was examined by using known kinase activatodinhibitors and examining the substrate specificity of the kinase [ 111. Histone type VII-S was a good substrate for the IRSK, whereas caseine, phosvitin and Kemptide were poor substrates. IRSK activity towards the insulin receptor was not significantly affected by cyclic AMP, cyclic GMP, or CaL+ + phosphatidylserine + diolein. The cyclic-AMP-dependent protein kinase inhibitor did not alter the phosph0serine:phosphotyrosine ratio. This indicates that the IRSK is distinct from cyclic-AMP-, cyclic-(;MI'-, and CaL+ -calmodulin-dependent protein kinases and C-kinase. IIeparin and spermine had at most small effects which, together with substrate specificity, indicate that the IRSK is distinct from casein kinase I (phosphorylates casein and phosvitin) and three insulin-activated kinases, namely insulin-activated Further studies are clearly required.
The location of sites of serine phosphorylation was explored using synthetic peptides. Peptide 1288-1302 containing Ser-1293/ 1294 was shown to be a substrate for the IRSK [7] . Incorporation of "P into the peptide was stimulated two-fourfold by insulin addition to the insulin receptor/IRSK preparation. Digestion of the phosphorylated peptide with trypsin, and two-dimensional analysis, revealed a major phosphoseryl peptide that had exactly the same migration as SS [7] . The deduced sequence of SS is N-Ser-Ser-His-Cys-GIn-Arg-C. 1201. I'eptide SS contains < 10% of the "P found in either SI or S2. 'I'he identity of the major phosphoseryl peptides (S 1 and S 2 ) is not known.
Insulin receptor PTPases
P'l'I'ases have the potential to control signal transduction by insulin in at least three ways: firstly, by regulating the level of autophosphorylation of tyrosines that control tyrosine activity towards other substratres; secondly, by regulating the level of autophosphoryl~ition of tyrosines that may control interaction of the insulin receptor with other proteins; and thirdly. by regulating the phosphorylation on tyrosine of proteins that are substrates for the insulin receptor tyrosine kinase. In rat liver the ma.jority of PTPase activity against autophosphorylated insulin receptor was recovered in the particulate fraction (70.6 f 3.8%) with the remainder in the soluble-cytosolic fraction 121 1. The PTPase activities in either fraction were sensitive to inhibition by vanadate, were fully active in the presence of RIITA and not appreciably affected by MgL+ or Ca'+ or by calmodulin using autoptiosphorylated insulin receptors as substrate 121 1. Particulate and soluble rat liver fractions were used as probes to study the role of individual tyrosine phosphorylation sites of the insulin receptor in kinase activation and to study the mechanism of dephosphorylation of autophosphorylated insulin receptor. This is important because these fractions contain the native spectrum of PTPases found in v i~o .
Dephosphorylation of insulin receptor autophosphorylation sites
Insulin receptor was maximally phosphorylated by using a high [ y-"P] A'I'P concentration (250 p v ) and an extended incubation time (30 min at 2TC) under conditions that minimized serine phosphorylation 1221. Autophosphorylations were terminated with RDTA and the autophosphorylated insulin receptor incubated with rat liver preparations of particulate and soluble PTPase. Dephosphorylation of insulin receptor autophosphorylation sites was analysed by two-dimensional tryptic-peptide mapping of /?-subunits on cellulose thin-layer plates. A complicated pattern of tryptic phosphopeptides was obtained because there are at least seven autophosphorylation sites and because certain peptides were incompletely digested with trypsin. The 'I'ry-1 1 SO autophosphorylation domain, which contains Tyr-1146, -1 150 and -1 1 5 I , was recovered as peptides monophosphorylated (Cl), bisphosphorylated (N2 and 133) and trisphosphorylated (A 1 and A2). I'he C-terminal autophosphorylation domain, which contains Tyr-1316 and -1322, was recovered as peptides bisphosphorylated (13 1) and monophosphorylated (NI'I). The putative juxtamembrane autophosphorylation domain yielded peptides C3 and Cl', which may represent bisphosphorylated and monophosphorylated prptides, respectively [22] . Fig. 2 shows the dephosphorylation of the various phosphorylation sites in autophosphorylated insulin receptor by the rat liver particulate PTPase. The 0 min panel shons that the autophosphorylated insulin receptor used as substrate yielded four major phosphotyrosyl tryptic peptides: A2 + A1 derived from insulin receptor trisphosphorylated in the Tyr-I 150 domain; H1 derived from insulin receptor trisphosphorylated in the C-terminal domain; and C3 which is believed to be derived from insulin receptor bisphosphorylated in the juxtamembrane domain, with the near-complete absence of partially phosphorylated peptides. The most striking feature of the time course of dephosphorylation was the very rapid disappearance of insulin receptors trisphosphorylated in the Tyr-1150 domain; e.g., 85% of peptides A 2 + A l disappeared in the first 2 min whereas the C-terminal (€3 1) and putative juxtamembrane ((2.3) phosphorylation sites were largely untouched. Thus, the Tyr-1150 domain in the trisphosphorylated form is exquisitely sensitive to dephosphorylation. Disappearance of the trisphosphorylated Tyr-1 150 domain was associated with increases in the bisphosphorylated derivative (I32 + R3), and then the monophosphorylated derivative ( C l ) as the bisphospho species disappeared. As the time course of dephosphorylation progressed. the C-terminal (HI -N P l ) and putative juxtamembrane (C3 + e l ' ) domains were dephosphorylated [22] .
The rat liver soluble PTPase fraction elicited a broadly similar pattern of dephosphorylation to that obtained with the rat liver particulate fraction. Thus, although the soluble and particulate fractions . . appear to contain more than one species of PTPase (see below), the overall PTPase specificity of the two fractons towards insulin receptor autophosphorylation sites was similar.
The mechanism of dephosphorylation of the trisphosphorylated Tyr-1 1 50 domain was analysed by V8-cleavage of tryptic peptides. V8 cleaves between residues 1 146 and 1 1 501 1 15 1, presumably at the C-terminal side of Glu-1147. H3 and €32 were present in a ratio of approximately 25: 1. Analysis of R 3 derived from incubations with either particulate or soluble PTPase showed that 15.2-19.7% of the bisphosphorylated H3 species was phosphorylated on both Tyr-1 1 50 and -1 15 1 ; the remainder were phosphorylated on Tyr-1146 and -1 150 or -1 15 1 [22] . These results indicate that the phosphatasecatalysed tris-bis transition predominantly (80-85%) involved removal of phosphate from one of the twin phosphotyrosyl residues, 1150 or 115 1. Thus, the exquisite sensitivity of the trisphosphorylated form of the Tyr-1150 domain to dephosphorylation appears to be largely conferred by the vicinal pair of phosphotyrosines.
Site-specific dephosphorylation and deactivation of the insulin receptor tyrosine kinase
The tyrosine kinase activity of the insulin receptor was assayed during dephosphorylation with synthetic peptide 1142-1 1.53 of the insulin receptor [23] . At concentrations in the 1-5 mhi range this peptide also inhibits insulin receptor autophosphorylation and consequently reactivation of tyrosine kinase activity which may otherwise occur during the assay of tyrosine kinase activity [ 1 1, 241.
Incubation of insulin receptor autophosphorylated in the presence of insulin with either rat liver particulate or soluble PTPase resulted in a reduction of the tyrosine kinase activity to a level that plateaued at -25-31%. In contrast the tyrosine kinase activity of insulin-stimulated non-phosphorylated insulin receptor remained stable at -18-21% during incubation with either phosphatase. Thus, insulin receptor tyrosine kinase activation, induced by insulin-stimulated autophosphorylation was largely reversed by PTPases. This deactivation of the tyrosine kinase was highly sensitive to PTPase action and correlated best with disappearance of insulin receptor trisphosphorylated in the Tyr-1 1 50 domain (Fig. 2) . Dephosphorylation of the bis-and mono-phosphorylated forms of the Tyr-1 1 50 domain generated during dephosphorylation or of phosphorylation sites in the Cterminal or putative juxtamembrane domains, occurred three to > 10-fold more slowly than deactivation of the tyrosine kinase, and these phosphorylated species did not appear to appreciably ( < 20%) contribute to tyrosine kinase activation.
These results indicate that the transition from the tris-to bis-phosphorylated form of the Tyr-1 1 50 domain acts as an important switch for deactivation of the insulin receptor tyrosine kinase during dephosphorylat ion.
The key activating role of the trisphosphorylated Tyr-1150 domain species of the human insulin receptor found in this study during Volume 20 dephosphorylation supports correlations made between the tyrosine kinase activity of the rat and mouse insulin receptor and site occupancy during phosphorylation [2S, 261 and the observation that proteolytic removal of the C-terminal domain does not affect the tyrosine kinase activity of the rat insulin receptor [27] . Additionally, mutant insulin receptor molecules in which tyrosine residues 11 SO or 1150 and 1151 have been replaced by phenylalanine exhibit a dramatic impairment of the ability of insulin to stimulate substrate phosphorylation [2X] . There is controversy, however, over the effects of mutation of Tyr-1 146 on insulin-stimulated substrate phosphorylation; Wilden et al. [24] have observed inhibition whereas Zhang et al. [29] have found normal activation. The results of Zhang et al. may imply that insulin receptor bisphosphorylated on Tyr-1 1 SO and -1 15 1 is activated. These findings also contradict the study of Flores-Riveros et al. [26] in which the appearance of the bisphosphorylated species, of which -37.5% were phosphorylated on the vicinal tyrosines, preceded tyrosine kinase activation during phosphorylation. Nonetheless the proportion of the bisphosphorylated Tyr-1 1 SO domain species phosphorylated on Tyr-1 1 SO and -1 15 1 formed during phosphorylation or dephosphorylation is only 10-20%. Thus, with either Tyr-1 1 SO or -1 IS 1 being phosphorylated last and dephosphorylated first, tyrosine kinase activation would still correlate well with trisphosphorylation of the three tyrosines even if the bisphosphorylated Tyr-1 1 SO/ 1 15 1 species was activated. Because of the small proportion of the bisphosphorylated Tyr-1 1.501 1 15 1 species generated by PTPase action, it was not possible to determine whether this species played a role in tyrosine kinase activation. Clearly, however, the predominant ( > 80%) form of the bisphosphorylated Tyr-1 1 SO domain species generated by the PTPases, which was phosphorylated on Tyr-1146 and -1 150 or -1 15 1, appeared deactivated. Additionally, this species has been trapped during phosphorylation by including anti-phospho-tyrosine antibody and shown to have a tyrosine kinase activity comparable with that of the non-phosphorylated insulin receptor [ZS] .
The rapid dephosphorylation of the trisphosphorylated Tyr-1 1 SO domain species and deactivation of tyrosine kinase activity by PTPases may offer a sensitive mechanism for terminating or regulating insulin receptor tyrosine kinase action and insulin signalling (Fig. 3) . This mechanism is likely to be of significance in viuo for a number of reasons.
Firstly, the PTPase activity in cells is high, e.g. The nature and identity of PTPases in human placenta and rat liver active against autophosphorylated insulin receptor was probed using an insulinreceptor-related peptide phosphorylated on tyrosine (peptide 1142-1153) [33] . Two species of PTPase were purified partially from the particulate and soluble fractions of human placenta [34] . Properties of the PTPases indicated that they corresponded to subtypes 1A and 1H. Both subtypes appeared capable of dephosphorylating all autophosphorylation sites in three domains of the insu-lin receptor. with no appreciable difference in the pattern of dephosphorylation detected by twodimensional tryptic peptide mapping. The Tyr-1 1 SO domain in trisphosphorylated form was exquisitely sensitive to the action of both PTPases. as found for the PTPases in liver fractions (see above). As the PTPases identified possessed high affinities for substrates and exhibited high activities in cells they may be important in vivo in controlling or reversing autophosphorylation-induced events. Most of our studies with rat liver were performed with the particulate fraction, as the bulk of PTI'ase resides here. At least three species of P7'Pase activity were resolved by chromatography on polylysine-agarose using the peptide as substrate. Similar results were obtained using phosphotyrosyl myelin basic protein or reduced carboxyamidomethylated and maleylated lysozyme as substrate [ 3 5 ] . One of these PTPases appears to be of high molecular weight, the other two of low molecular weight with one seemingly related to placental PTPase 1H. All these PTPases are capable of dephosphorylating autophosphorylated insulin receptor in nitro.
A major goal now is to identify which species of PTPases interact with the insulin receptor in the cell and mediate physiological control and reversal of insulin signalling.
